DURHAM, N.C., May 16, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the Company), a leading global contract research organization (CRO), today announced the appointment of Machelle Sanders to...
For the three months ended March 31, 2024, from continuing operations: Revenues of $662.1 millionGAAP net loss of $81.6 millionAdjusted EBITDA of $29.5 millionGAAP and adjusted diluted earnings...
DURHAM, N.C., May 06, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the Company), a leading global contract research organization (CRO), today announced an updated issuance date for the...
DURHAM, N.C., April 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the Company), a leading global contract research organization (CRO), today announced that it will release its first quarter...
Fortrea Increases Patient Access Capabilities
Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results
DURHAM, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the œCompany), a leading global contract research organization (CRO), today announced an industry partnership with founding...
DURHAM, N.C., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and...
Global CRO Fortrea and life sciences software provider Medidata are teaming up to increase access for diverse patients to participate in clinical trials.
DURHAM, N.C., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the appointment of John Doyle Dr.P.H., as its new...